Please see below for a list of search results.
Since 5 July 2008, the HTA has regulated the collection, testing, processing, storage, distribution, import and export of cord blood. In the UK these are ‘licensable activities’ and can only lawfully take place under an HTA licence.
Protecting public and professional confidence requires us to protect the foundations on which confidence is built. We believe that confidence is maintained if the core principles contained within the Human Tissue Act are adhered to. These principles are:
The HTA aims to be a right-touch regulator which complies with the principles of better regulation, and supports the Government’s aims with regard to deregulation.
The HTA has always been active in seeking ways it can advance public confidence and better target its regulation.
Underpinning both delivery and development activity are the choices we make about how we best manage our people and resources.
While the Executive implements this Strategy by way of business plans, there are a number of mechanisms in place by which the Authority steers, scrutinises and reviews performance.
This report provides updates on progress against a set of key performance indicators (KPIs) which collectively give an indication of the health of the business. The Authority monitors progress using a ‘traffic light’ system, whereby each indicator is assessed as red, amber or green.
This report provides the Authority with assurances on the management of financial resources. The report provides commentary on the overall financial position, income and expenditure variances, forecast outturns, financial performance and financial risks.
The risk register is reviewed monthly by the Executive and changes are highlighted at each Authority meeting. An overview of the key risks facing the organisation is included, so the Authority can assure itself that risks are being identified and managed appropriately.